BioFuse Medical Technologies Appoints Dr. David Battleman as President & Chief Executive Officer
Position
Chief Executive Officer
Company
BioFuse Medical Technologies
MelbourneManufacturingBiotechnologyHealth CareMedicalMedical DeviceDescription
Dr. David Battleman, MD, MBA, MSc, has been appointed as President & Chief Executive Officer of BioFuse Medical Technologies. His extensive experience in healthcare & life science technology development & commercialization makes him an ideal leader to guide BioFuse through its next phase of growth.
Quick answer
BioFuse Medical Technologies Appoints Dr. David Battleman as President & Chief Executive Officer (March 26, 2024). BioFuse Medical Technologies is based in Melbourne, Florida, United States.
- Who is the new Chief Executive Officer at BioFuse Medical Technologies?
- BioFuse Medical Technologies named David Battleman Chief Executive Officer, announced March 26, 2024.
- What did BioFuse Medical Technologies announce on March 26, 2024?
- Dr. David Battleman, MD, MBA, MSc, has been appointed as President & Chief Executive Officer of BioFuse Medical Technologies. His extensive experience in healthcare & life science technology development & commercialization makes him an ideal leader to guide BioFuse through its next phase of growth.
- What does BioFuse Medical Technologies do?
- BioFuse Medical Technologies, Inc. is a privately held medical device company headquartered in Melbourne, Florida.
- Where is BioFuse Medical Technologies based?
- BioFuse Medical Technologies is based in Melbourne, Florida, United States.
- Which similar companies made leadership changes around the same time?
- RIVANNA (March 29, 2024), Lifecore Biomedical (March 20, 2024), AIROS Medical (April 11, 2024) and Olympus Corporation of the Americas (April 19, 2024) also announced leadership changes within 45 days of BioFuse Medical Technologies.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Medical Device
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- RIVANNA Names Craig Loomis as Senior Director of Product Management (March 29, 2024)
- Lifecore Biomedical Appoints Paul Josephs as CEO (March 20, 2024)
- AIROS Medical, Inc. Names Darren M. Behuniak as Chief Operating Officer (April 11, 2024)
- Olympus appoints Julien Sauvagnargues as President and CEO of Olympus Corporation of the Americas (April 19, 2024)
- NeoChord Appoints Todd Berg as Chief Executive Officer (February 29, 2024)
- OssDsign Appoints Tom Buckland as Chief Technical Officer (February 29, 2024)
Who to call at BioFuse Medical Technologies, and when
A new leader at BioFuse Medical Technologies brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day BioFuse Medical Technologies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at BioFuse Medical Technologies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at BioFuse Medical Technologies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment BioFuse Medical Technologies changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
BioFuse Medical Technologies changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.